Induction of hyperresponsiveness in human airway tissue by neutrophils - Mechanism of action

Clinical and Experimental Allergy

Volumn 26, Issue 5, 1996, Pages 549-556

  Anticevich, S Z ^a   Hughes, J M ^a   Black, J L ^a   Armour, C L ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Albumin; Antagonists; Contraction; Human airways; Hyperresponsiveness; Neutrophils; Sensitization

Indexed keywords

ALBUMIN; APAFANT; LEUKOTRIENE D4; NEUROKININ A; SAREDUTANT; THROMBOCYTE ACTIVATING FACTOR; VAPIPROST; VERLUKAST;

ADULT; ARTICLE; ASTHMA; BRONCHUS; CELL INFILTRATION; ETIOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; BRONCHI; BRONCHIAL HYPERREACTIVITY; CELL DIFFERENTIATION; ELECTRIC STIMULATION; HUMANS; IMMUNIZATION; NEUTROPHILS; SERUM ALBUMIN;

EID: 0029994272     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.1996.tb00575.x     Document Type: Article

References (50)

1. Peat JK, Gray EJ, Mellis CM, Leeder SR, Woolcock AJ. Differences in airway responsiveness between children and adults living in the same environment: an epidemiological study in two regions of New South Wales. Eur Respir J 1994; 7:1805-13.
2. Bousquet J, Chanez P, Lacoste JY et al. Indirect evidence of bronchial inflammation assessed by titration of inflammatory mediators in BAL fluid of patients with asthma. J Allergy Clin Immunol 1991; 88:649-60.
3. Smith HR, Larsen GL, Cherniack RM et al. Inflammatory cells and eicosanoid mediators in subjects with late asthmatic responses and increases in airways responsiveness. J Allergy Clin Immunol 1992; 89:1076-84.
4. Fabbri LM, Boschetto P, Zocca E et al. Bronchoalveolar neutrophilia during late asthmatic reaction induced by toluene diisocyanate. Am Rev Respir Dis 1987; 136:36-42.
5. Metzger WJ, Zavala D, Richerson HB et al. Local allergen challenge and bronchoalveolar lavage of allergic asthmatic lungs. Am Rev Respir Dis 1987; 135:433-40.
6. Carroll MP, Durham SR, Walsh G, Kay AB. Activation of neutrophils and monocytes after allergen and histamine-induced bronchoconstriction. J Allergy Clin Immunol 1985; 75:290-6.
7. Fabbri LM, Aizawa H, Alpert SE et al. Airway hyperresponsiveness and changes in cell counts in bronchoalveolar lavage after ozone exposure in dogs. Am Rev Respir Dis 1984; 129:288-91.
8. Marsh WR, Irvin CG, Murphy KR, Behrens L, Larsen G. Increases in airway reactivity to histamine and inflammatory cells in bronchoalveolar lavage after the late asthmatic response in the animal model. Am Rev Respir Dis 1985; 131:875-9.
9. Wardlaw AJ, Dunnette S, Gleich GJ, Collins JV, Kay AB. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Am Rev Respir Dis 1988; 137:62-9.
10. Fabbri LM, Picotti G, Mapp CE. Late asthmatic reactions, airway inflammation and chronic asthma in TDI sensitized subjects. Eur Respir J 1991; 4, Suppl. 13:136s-8s.
11. Smith HR, Larsen GL, Cherniack RM et al. Inflammatory cells and the eicosanoid mediators in subjects with late asthmatic responses and increases in airway responsiveness. J Allergy Clin Immunol 1992; 89:1076-84.
12. Martin RJ, Cicutto LC, Smith HR, Ballard RD, Szefler SJ. Airways inflammation in nocturnal asthma. Am Rev Respir Dis 1991; 143:51-357.
13. Fahy JY, Kim KW, Liu J, Boushey HA. Cellular and biochemical analysis of sputum from asthmatic subjects in exacerbation; evidence of prominent neutrophilic inflammation. Am J Respir Crit Care Med 1994; 149:A572.
14. Sur S, Crotty TB, Kephsrt GM et al. Sudden-onset fatal asthma: A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am Rev Respir Dis 1993; 148:713-9.
15. Papageorgiou N, Durham SR, Walsh GM et al. Complement receptor enhancement as evidence of neutrophil activation after exercise-induced asthma. Lancet 1983; 26: 1220-3.
16. Durham SR, Carroll M, Walsh GM, Kay AB. Leukocyte activation in allergen-induced late-phase asthmatic reactions. N Eng J Med 1984; 29:1398-402.
17. Carlson M, Hakansson L, Peterson C, Stalenheim G, Venge P. Secretion of granule proteins from eosinophils and neutrophils is increased in asthma. J Allergy Clin Immunol 1991; 87:27-33.
18. Hallahan AR, Armour CL, Black JL. Products of neutrophils and eosinophils increase the responsiveness of human isolated bronchial tissue. Eur Respir J 1990; 3:554-8.
19. Hughes JM, McKay KO, Johnson PR et al. Neutrophil-induced human bronchial hyperresponsiveness in vitro-pharmacological modulation. Clin Exp Allergy 1993; 23:251-6.
20. Calhoun WJ, Bush RK, Salisbury SM, Stevens CA. Enhanced reactive oxygen species metabolism of airspace cells and airway inflammation follow antigen challenge in human asthma. J Allergy Clin Immunol 1990; 86:306-13.
21. Fabbri LM, Maestrelli P, Saetta M, Mapp CE. Airway inflammation during late asthmatic reactions induced by toluene diisocynate. Am Rev Respir Dis 1991; 143:S37-S38.
22. Johnson PRA, Armour CL, Black JL. The action of platelet activating factor and its antagonism by WEB 2086 on human isolated airways. Eur Respir J 1990; 3:55-60.
23. Rao AK, Koike K, Day HJ, Smith JB, Holmsen H. Bleeding disorder associated with albumin-dependent partial deficiency in platelet thromboxane production. Am J Clin Pathol 1985; 83:687-96.
24. Fitzpatrick FA, Morton DR, Wynalda MA. Albumin stabilizes leukotriene A4. J Biol Chem 1982; 257:4680-3.
25. Dratewka-Kos E, Kindl B, Tinker DO. The modulation of serum albumin of rabbit platelet aggregation in response to exogenous sodium arachidoniate. Can J Biochem Cell Biol 1985; 63:792-802.
26. Spector AA, Hoak JC, Warner ED, Fry GL. Utilization of long-chain free fatty acids by human platelets. J Clin Invest 1970; 49:1489-96.
27. 2. FEBS Letters 1977; 82:321-4.
28. 2. Identification of products formed in vitro. J Biol Chem 1983; 258:11713-8.
29. Heinsohn C, Polgar P, Fishman J, Taylor L. The effect of bovine serum albumin on the synthesis of prostaglandin and incorporation of [3H] acetate into platelet-activating factor. Arch Biochem Biophys 1987; 257:251-8.
30. Stuart MJ, Gerrard JM, White JG. The influence of albumin and calcium on human platelet arachidonic acid metabolism. Blood 1980; 55:418-23.
31. 2. Biochim Biophys Acta 1986; 878:394-403.
32. Elsbach P, Pettis P. Phospholipase activity associated with serum albumin. Biochim Biophys Acta 1973; 296:89-93.
33. Black JL, Marthan R, Armour CL, Johnson PRA. Sensitization alters contractile responses and calcium influx in human airway smooth muscle. J Allergy Clin Immunol 1989; 84:440-7.
34. Villanove X, Marthan R, De Lara JM et al. Sensitization decreases relaxation in human isolated airways. Am Rev Respir Dis 1993; 148:107-12.
35. Armour CL, Johnson PRA, Black JL. Potentiation of contraction of rabbit airway smooth muscle by some cyclooxygenase products. Prostaglandins 1988; 35:959-68.
36. Black JL, Johnson PRA, Alfredson M, Armour CL. Inhibition by prostaglandin E2 of neurotransmission in rabbit but not human bronchus ..... A calcium related mechanism. Prostaglandins 1989; 37:317-30.
37. Armour CL, Johnson PRA, Alfredson ML, Black JL. Characterization of contractile prostanoid receptors on human airway smooth muscle. Eur J Pharmacol 1989; 165:215-22.
38. Lumley P, White BP, Humphrey PP. GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro. Br J Pharmacol 1989; 97:783-94.
39. Casals-Stenzel J, Muacevic G, Weber K. Pharacological action of WEB 2086, a new specific antagonist of platelet activating factor. J Pharm Exp Ther 1987; 241:974-81.
40. O'Donnell SR, Barnett CJK. pA2 values for antagonists of platelet activating factor on aggregation of rabbit platelets. Br J Pharmacol 1988; 94:437-42.
41. Jones TR, Zamboni R, Belley M et al. Pharmacology of the leukotriene antagonist verlukast: The (R)-enantiomer of MK-571. Can J Physiol Pharmacol 1991; 69:1847-54.
42. Edmonds-Alt X, Vilian P, Goulaouic P et al. A potent and selective non-peptide antagonist of the neurokinin a (NK2) receptor. Life Sciences 1992; 50:101-6.
43. Advenier C, Naline E, Toty L et al. Effect on the isolated human bronchus of SR 48968, a potent and selective nonpeptide antagonist of the neurokinin A (NK2) receptors. Am Rev Respir Dis 1992; 146:1177-81.
44. Advenier C, Rouissi N, Nguyen QT et al. Neurokinin A (NK2) receptor revisited with Sr 48968, a potent nonpeptide antagonist. Biochem Biophys Res Comm 1992; 183:1418-24.
45. Dahlen S-E, Hedqvist P, Hammarstrom S, Samuelsson S. Leukotrienes are potent constrictors of human bronchi. Nature 1980; 288:484-6.
46. Hana CJ, Bach MK, Pare PD, Schellenberg RR. Slow-reacting substances (leukotrienes) contract human airway and pulmonary vascular smooth muscle in vitro. Nature 1981; 290:343-4.
47. Deykin D, Russell FA, Vaillancourt R. The use of high pressure liquid chromatography (HPLC) for the separation of radiolabeled arachidonic acid and its metabolites produced by the thrombin-treated human platelets II. Establishment of optimal assay conditions. Prostaglandins 1979; 18:19-27.
48. Yoshida N, Aoki N. Release of arachidonic acid from human platelets. A key role for the potentiation of platelet aggregability in normal subjects as well as in those with nephrotic syndrome. Blood 1978; 52:969-77.
49. Irvin CG, Baltopoulos G, Henson P. Airway hyperreactivity produced by products of phagocytozing neutrophils. Am Rev Respir Dis 1985; 131:A278.
50. Weichman BM, Muccitelli RM, Osborn RR et al. In vitro and in vivo mechanisms of leukotriene-mediated broncho-constriction in the guinea pig. J Pharmacol Exp Ther 1982; 222:202-8.